Skip to content

Combined Fractional CO2 Laser With Topical Tioconazole Versus Q-switched Nd:YAG Laser in the Treatment of Onychomycosis; a Randomized Controlled Trial

Combined Fractional CO2 Laser With Topical Tioconazole Versus Q-switched Nd:YAG Laser in the Treatment of Onychomycosis; a Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05999474
Enrollment
30
Registered
2023-08-21
Start date
2022-09-01
Completion date
2023-10-01
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onychomycosis of Fingernail

Brief summary

Our aim is to assess the clinical efficacy and the safety of fractional CO2 laser combined with topical tioconazole versus Q-switched Nd:YAG laser in the treatment of OM.

Interventions

DRUGTopical tioconazole

Laser

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* • Age group \>18 years. * Patients of both genders. * Patients with OM any type.

Exclusion criteria

* • Pregnancy * Localized bacterial infection around the affected nail * Concomitant nails disease that causes nail dystrophy or discoloration such as psoriasis, lichen planus and atopic dermatitis that may interfere with diagnosis and treatment * Hypersensitivity to terbinafine * Intake of oral antifungal medication within the last 3 months or used topical antifungal medication within the last 2 weeks prior to the laser treatment

Design outcomes

Primary

MeasureTime frameDescription
treatment of onychomycosis6 monthsPatient Evaluation (Clinical percentage of improvement). 2- Improvement of OM (assessed by investigator). 3-Percentage of grading and OSI score improvement

Countries

Egypt

Contacts

Primary ContactAmira Elbendary, MD
aelbendary@kasralainy.edu.eg01555668584
Backup ContactKhadiga Sayed, MD
Diga1980@hotmail.com+201060105697

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026